Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idelalisib rollover study for subjects previously treated with GS-9820
NL-OMON43418Phase 4Active, not recruiting
- Sponsor
- Gilead Sciences
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of idelalisib in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), sponsored by Gilead Sciences. Started May 2016; status: active, not recruiting.
02
Drugs
idelalisib
03
Conditions
chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Beyond the preview
Go deeper on NL-OMON43418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43418.